Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 3/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9465765 | 0.87 | PTGS2 (0.38) | PTGS2KDM4EPPARG | |
| SCHEMBL10044416 | 0.82 | PTGS2 (0.43) | PTGS2 | |
| SCHEMBL10044413 | 0.78 | PTGS2 (0.53) | PTGS2KDM4E | |
| SCHEMBL7926564 | 0.77 | GAA (0.44) | PTGS2KDM4EPPARG | |
| SCHEMBL14074048 | 0.77 | PTGS2 (0.38) | PDE4APDE4BPDE4CPDE4DPTGS2 | |
| SCHEMBL11162605 | 0.74 | KDM4E (0.53) | PDE4APDE4BPDE4CPDE4DKDM4E | |
| SCHEMBL10196841 | 0.74 | GAA (0.40) | PTGS2KDM4E | |
| SCHEMBL18102200 | 0.72 | LMNA (0.36) | PTGS2KDM4EPPARG | |
| SCHEMBL11356386 | 0.72 | PTGS2 (0.42) | PTGS2KDM4E | |
| SCHEMBL3111457 | 0.72 | PDE4A (0.44) | PDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6413966-B1 | SEROTONERGIC AND CENTRAL DOPAMINERGIC ACTIVITY; AFFINITY FOR 5HT1A AND 5HT2 SEROTONIN AND D2 DOPAMINE RECEPTORS; ATYPICAL ANTIPSYCHOTICS; SCHIZOPHRENIA | FAES, FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. | 2002-07-02 | — | — | US | disclosed |
| EP-1057820-A1 | Arylpiperazinylalkyl-3(2H)-pyridazinones as serotonin 5HT and dopamine D2 receptor agonists | FAES, Fabrica Espanola de Productos Quimicos y Farmaceuticos, S.A. (ES) | 2000-12-06 | — | — | EP | disclosed |